Edwards Lifesciences Down Over 22%, on Pace for Largest Percent Decrease Since October 2000 — Data Talk
Edwards Lifesciences Corporation (EW) is currently at $67.54, down $19.41 or 22.32%
--Would be lowest close since Nov. 29, 2023, when it closed at $67.43
--On pace for largest percent decrease since Oct. 31, 2000, when it fell 41.42%
--Currently down three consecutive days; down 23.24% over this period
--Worst three day stretch since the three days ending Nov. 2, 2000, when it fell 38.15%
--Down 26.88% month-to-date; on pace for worst month since Oct. 2000, when it fell 38.4%
--Down 11.42% year-to-date
--Down 48.32% from its all-time closing high of $130.68 on Dec. 30, 2021
--Down 18.30% from 52 weeks ago (July 27, 2023), when it closed at $82.67
--Down 29.32% from its 52-week closing high of $95.56 on March 28, 2024
--Up 9.45% from its 52-week closing low of $61.71 on Oct. 27, 2023
--Traded as low as $63.00; lowest intraday level since Nov. 1, 2023, when it hit $62.52
--Down 27.54% at today's intraday low; largest intraday percent decrease since Oct. 31, 2000, when it fell as much as 41.69%
--Worst performer in the S&P 500 today
--Fifth most active stock in the S&P 500 today
All data as of 9:49:38 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 25, 2024 10:07 ET (14:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks